本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tscan Therapeutics, Inc.

2.48
0.0000
盘后2.45-0.0300-1.21%19:38 EDT
成交量:71.19万
成交额:172.11万
市值:1.41亿
市盈率:-1.03
高:2.57
开:2.48
低:2.28
收:2.48
52周最高:6.23
52周最低:1.02
股本:5,674.80万
流通股本:4,403.13万
量比:0.94
换手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-2.4102
每股收益(LYR):-2.2530
净资产收益率:-63.33%
总资产收益率:-26.77%
市净率:0.80
市盈率(LYR):-1.10

数据加载中...

2024/11/01

重要事件披露

Form 8-K - Current report
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/17

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/10

SEC问询函

Form CORRESP - Correspondence
2024/04/10

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/08

重要事件披露

Form 8-K - Current report
2024/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]